Researcher
Genevieve Laureys
- Disciplines:Endocrinology and metabolic diseases, Paediatrics and neonatology, Nursing
Affiliations
- Department of Internal Medicine and Pediatrics (Department)
Member
From1 Oct 2018 → Today - Department of Pediatrics and medical genetics (Department)
Member
From1 Oct 2000 → 30 Sep 2018
Projects
1 - 3 of 3
- Predisposition in a family with two pediatric patients with Hodgkin lymphoma Non-BurkettFrom1 Jun 2016 → 31 May 2018Funding: Foundations, funds and other with scientific goal
- Research Assignment dr. Tim Lammens ihkv the ongoing clinical-translational research at the department of Pediatric Hematology-Oncology and Stem Cell TransplantationFrom1 Jun 2015 → 30 Sep 2019Funding: Nonprofit institution or equivalents
- Deregulated transcriptional networks of regulatory miRNAs and protein coding genes in the pathogenesis of cancerFrom1 Jan 2010 → 31 Oct 2016Funding: BOF - Concerted Research Project from 1994
Publications
1 - 10 of 24
- Predicting outcomes with circulating adrenergic neuroblastoma mRNAs in children with relapsed and refractory neuroblastoma : a BEACON-Neuroblastoma biomarker study(2022)Volume: 40
Authors: Lucas Moreno, Rebekah Weston, Virginie Viprey, Andrei Tchirkov, Maria Corrias, Tim Lammens, Juliet Gray, Cormac Owens, Jennifer Laidler, Marion Gambart, et al.
Number of pages: 1 - The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness(2020)
Authors: Liselot Mus, Irina Lambertz, Shana Claeys, Candy Kumps, Wouter Van Loocke, Christophe Van Neste, Ganesh Umapathy, Marica Vaapil, Christoph Bartenhagen, Genevieve Laureys, et al.
- ALK positively regulates MYCN activity through repression of HBP1 expression(2019)
Authors: Shana Claeys, Geertrui Denecker, Kaat Durinck, Bieke Decaesteker, Liselot Mus, Siebe Loontiens, Suzanne Vanhauwaert, Kristina Althoff, Caroline Wigerup, Daniel Bexell, et al.
Pages: 2690 - 2705 - The strategic plan for paediatric cancer treatment in Belgium(2019)
Authors: A Van Damme, Barbara De Moerloose, B Brichard, A Ferster, B Heenen, Genevieve Laureys, Koen Norga, C Piette, Jutte Van Der Werff Ten Bosch, Anne Uyttebroeck
Pages: 21 - 26 - Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing(2019)
Authors: Charlotte Derpoorter, Karl Vandepoele, Araceli Diez Fraile, Katrien Vandemeulebroecke, Bram De Wilde, Franki Speleman, Nadine Van Roy, Tim Lammens, Genevieve Laureys
- Genes at the crossroad of primary immunodeficiencies and cancer(2018)
Authors: Charlotte Derpoorter, Victoria Bordon Maria, Genevieve Laureys, Filomeen Haerynck, Tim Lammens
- Topotecan-vincristine-doxorubicin in stage 4 high risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC : a SIOPEN study(2018)
Authors: Loredana Amoroso, Giovanni Erminio, Guy Makin, Andrew DJ Pearson, Penelope Brock, Dominique Valteau-Couanet, Victoria Castel, Marlène Pasquet, Genevieve Laureys, Caroline Thomas, et al.
Pages: 148 - 155 - Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis(2018)
Authors: Maria V Corrias, Stefano Parodi, Andrei Tchirkov, Tim Lammens, Ales Vicha, Claudia Pasqualini, Catarina Träger, Yania Yáñez, Sandro Dallorso, Luigi Varesio, et al.
- Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN) : a multicentre, randomised, phase 3 trial(2018)
Authors: Ruth Ladenstein, Ulrike Poetschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens, et al.
Pages: 1617 - 1629 - Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study(2018)
Authors: Daniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.